Industry Research Reports

Home > Reports > Service & Software > AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

AI-enabled Imaging Modality- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 81 Pages

Report ld: 4022257

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.

This report aims to provide a comprehensive presentation of the global market for AI-enabled Imaging Modality, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-enabled Imaging Modality by region & country, by Type, and by Application.

The AI-enabled Imaging Modality market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-enabled Imaging Modality.

MARKET SEGMENTATION

By Company

Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon
Hologic
Butterfly Network
Hyperfine
United Health Imaging
Yorlabs
Nanox

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Computed Tomography
MRI
X-Ray
Ultrasound
Positron Emission Tomography
Others

Segment by Application

Hospital
Cilinic
Labs

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI-enabled Imaging Modality company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI-enabled Imaging Modality in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI-enabled Imaging Modality in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI-enabled Imaging Modality Product Introduction

1.2 Global AI-enabled Imaging Modality Market Size Forecast (2020-2031)

1.3 AI-enabled Imaging Modality Market Trends & Drivers

1.3.1 AI-enabled Imaging Modality Industry Trends

1.3.2 AI-enabled Imaging Modality Market Drivers & Opportunity

1.3.3 AI-enabled Imaging Modality Market Challenges

1.3.4 AI-enabled Imaging Modality Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI-enabled Imaging Modality Players Revenue Ranking (2024)

2.2 Global AI-enabled Imaging Modality Revenue by Company (2020-2025)

2.3 Key Companies AI-enabled Imaging Modality Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI-enabled Imaging Modality Product Offered

2.5 Key Companies Time to Begin Mass Production of AI-enabled Imaging Modality

2.6 AI-enabled Imaging Modality Market Competitive Analysis

2.6.1 AI-enabled Imaging Modality Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by AI-enabled Imaging Modality Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-enabled Imaging Modality as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Computed Tomography

3.1.2 MRI

3.1.3 X-Ray

3.1.4 Ultrasound

3.1.5 Positron Emission Tomography

3.1.6 Others

3.2 Global AI-enabled Imaging Modality Sales Value by Type

3.2.1 Global AI-enabled Imaging Modality Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global AI-enabled Imaging Modality Sales Value, by Type (2020-2031)

3.2.3 Global AI-enabled Imaging Modality Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Cilinic

4.1.3 Labs

4.2 Global AI-enabled Imaging Modality Sales Value by Application

4.2.1 Global AI-enabled Imaging Modality Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global AI-enabled Imaging Modality Sales Value, by Application (2020-2031)

4.2.3 Global AI-enabled Imaging Modality Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global AI-enabled Imaging Modality Sales Value by Region

5.1.1 Global AI-enabled Imaging Modality Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global AI-enabled Imaging Modality Sales Value by Region (2020-2025)

5.1.3 Global AI-enabled Imaging Modality Sales Value by Region (2026-2031)

5.1.4 Global AI-enabled Imaging Modality Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America AI-enabled Imaging Modality Sales Value, 2020-2031

5.2.2 North America AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe AI-enabled Imaging Modality Sales Value, 2020-2031

5.3.2 Europe AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific AI-enabled Imaging Modality Sales Value, 2020-2031

5.4.2 Asia Pacific AI-enabled Imaging Modality Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America AI-enabled Imaging Modality Sales Value, 2020-2031

5.5.2 South America AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI-enabled Imaging Modality Sales Value, 2020-2031

5.6.2 Middle East & Africa AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI-enabled Imaging Modality Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions AI-enabled Imaging Modality Sales Value, 2020-2031

6.3 United States

6.3.1 United States AI-enabled Imaging Modality Sales Value, 2020-2031

6.3.2 United States AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.3.3 United States AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe AI-enabled Imaging Modality Sales Value, 2020-2031

6.4.2 Europe AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China AI-enabled Imaging Modality Sales Value, 2020-2031

6.5.2 China AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.5.3 China AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan AI-enabled Imaging Modality Sales Value, 2020-2031

6.6.2 Japan AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea AI-enabled Imaging Modality Sales Value, 2020-2031

6.7.2 South Korea AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia AI-enabled Imaging Modality Sales Value, 2020-2031

6.8.2 Southeast Asia AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India AI-enabled Imaging Modality Sales Value, 2020-2031

6.9.2 India AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

6.9.3 India AI-enabled Imaging Modality Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Koninklijke Philips N.V.

7.1.1 Koninklijke Philips N.V. Profile

7.1.2 Koninklijke Philips N.V. Main Business

7.1.3 Koninklijke Philips N.V. AI-enabled Imaging Modality Products, Services and Solutions

7.1.4 Koninklijke Philips N.V. AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.1.5 Koninklijke Philips N.V. Recent Developments

7.2 Siemens Healthineers AG.

7.2.1 Siemens Healthineers AG. Profile

7.2.2 Siemens Healthineers AG. Main Business

7.2.3 Siemens Healthineers AG. AI-enabled Imaging Modality Products, Services and Solutions

7.2.4 Siemens Healthineers AG. AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.2.5 Siemens Healthineers AG. Recent Developments

7.3 General Electric Company

7.3.1 General Electric Company Profile

7.3.2 General Electric Company Main Business

7.3.3 General Electric Company AI-enabled Imaging Modality Products, Services and Solutions

7.3.4 General Electric Company AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.3.5 General Electric Company Recent Developments

7.4 Canon

7.4.1 Canon Profile

7.4.2 Canon Main Business

7.4.3 Canon AI-enabled Imaging Modality Products, Services and Solutions

7.4.4 Canon AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.4.5 Canon Recent Developments

7.5 Hologic

7.5.1 Hologic Profile

7.5.2 Hologic Main Business

7.5.3 Hologic AI-enabled Imaging Modality Products, Services and Solutions

7.5.4 Hologic AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.5.5 Hologic Recent Developments

7.6 Butterfly Network

7.6.1 Butterfly Network Profile

7.6.2 Butterfly Network Main Business

7.6.3 Butterfly Network AI-enabled Imaging Modality Products, Services and Solutions

7.6.4 Butterfly Network AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.6.5 Butterfly Network Recent Developments

7.7 Hyperfine

7.7.1 Hyperfine Profile

7.7.2 Hyperfine Main Business

7.7.3 Hyperfine AI-enabled Imaging Modality Products, Services and Solutions

7.7.4 Hyperfine AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.7.5 Hyperfine Recent Developments

7.8 United Health Imaging

7.8.1 United Health Imaging Profile

7.8.2 United Health Imaging Main Business

7.8.3 United Health Imaging AI-enabled Imaging Modality Products, Services and Solutions

7.8.4 United Health Imaging AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.8.5 United Health Imaging Recent Developments

7.9 Yorlabs

7.9.1 Yorlabs Profile

7.9.2 Yorlabs Main Business

7.9.3 Yorlabs AI-enabled Imaging Modality Products, Services and Solutions

7.9.4 Yorlabs AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.9.5 Yorlabs Recent Developments

7.10 Nanox

7.10.1 Nanox Profile

7.10.2 Nanox Main Business

7.10.3 Nanox AI-enabled Imaging Modality Products, Services and Solutions

7.10.4 Nanox AI-enabled Imaging Modality Revenue (US$ Million) & (2020-2025)

7.10.5 Nanox Recent Developments

8 Industry Chain Analysis

8.1 AI-enabled Imaging Modality Industrial Chain

8.2 AI-enabled Imaging Modality Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI-enabled Imaging Modality Sales Model

8.5.2 Sales Channel

8.5.3 AI-enabled Imaging Modality Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI-enabled Imaging Modality Market Trends

Table 2. AI-enabled Imaging Modality Market Drivers & Opportunity

Table 3. AI-enabled Imaging Modality Market Challenges

Table 4. AI-enabled Imaging Modality Market Restraints

Table 5. Global AI-enabled Imaging Modality Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global AI-enabled Imaging Modality Revenue Market Share by Company (2020-2025)

Table 7. Key Companies AI-enabled Imaging Modality Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI-enabled Imaging Modality Product Type

Table 9. Key Companies Time to Begin Mass Production of AI-enabled Imaging Modality

Table 10. Global AI-enabled Imaging Modality Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-enabled Imaging Modality as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI-enabled Imaging Modality Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global AI-enabled Imaging Modality Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global AI-enabled Imaging Modality Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global AI-enabled Imaging Modality Sales Market Share in Value by Type (2020-2025)

Table 17. Global AI-enabled Imaging Modality Sales Market Share in Value by Type (2026-2031)

Table 18. Global AI-enabled Imaging Modality Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global AI-enabled Imaging Modality Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global AI-enabled Imaging Modality Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global AI-enabled Imaging Modality Sales Market Share in Value by Application (2020-2025)

Table 22. Global AI-enabled Imaging Modality Sales Market Share in Value by Application (2026-2031)

Table 23. Global AI-enabled Imaging Modality Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global AI-enabled Imaging Modality Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global AI-enabled Imaging Modality Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global AI-enabled Imaging Modality Sales Value by Region (2020-2025) & (%)

Table 27. Global AI-enabled Imaging Modality Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions AI-enabled Imaging Modality Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions AI-enabled Imaging Modality Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions AI-enabled Imaging Modality Sales Value, (2026-2031) & (US$ Million)

Table 31. Koninklijke Philips N.V. Basic Information List

Table 32. Koninklijke Philips N.V. Description and Business Overview

Table 33. Koninklijke Philips N.V. AI-enabled Imaging Modality Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Koninklijke Philips N.V. (2020-2025)

Table 35. Koninklijke Philips N.V. Recent Developments

Table 36. Siemens Healthineers AG. Basic Information List

Table 37. Siemens Healthineers AG. Description and Business Overview

Table 38. Siemens Healthineers AG. AI-enabled Imaging Modality Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Siemens Healthineers AG. (2020-2025)

Table 40. Siemens Healthineers AG. Recent Developments

Table 41. General Electric Company Basic Information List

Table 42. General Electric Company Description and Business Overview

Table 43. General Electric Company AI-enabled Imaging Modality Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI-enabled Imaging Modality Business of General Electric Company (2020-2025)

Table 45. General Electric Company Recent Developments

Table 46. Canon Basic Information List

Table 47. Canon Description and Business Overview

Table 48. Canon AI-enabled Imaging Modality Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Canon (2020-2025)

Table 50. Canon Recent Developments

Table 51. Hologic Basic Information List

Table 52. Hologic Description and Business Overview

Table 53. Hologic AI-enabled Imaging Modality Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Hologic (2020-2025)

Table 55. Hologic Recent Developments

Table 56. Butterfly Network Basic Information List

Table 57. Butterfly Network Description and Business Overview

Table 58. Butterfly Network AI-enabled Imaging Modality Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Butterfly Network (2020-2025)

Table 60. Butterfly Network Recent Developments

Table 61. Hyperfine Basic Information List

Table 62. Hyperfine Description and Business Overview

Table 63. Hyperfine AI-enabled Imaging Modality Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Hyperfine (2020-2025)

Table 65. Hyperfine Recent Developments

Table 66. United Health Imaging Basic Information List

Table 67. United Health Imaging Description and Business Overview

Table 68. United Health Imaging AI-enabled Imaging Modality Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI-enabled Imaging Modality Business of United Health Imaging (2020-2025)

Table 70. United Health Imaging Recent Developments

Table 71. Yorlabs Basic Information List

Table 72. Yorlabs Description and Business Overview

Table 73. Yorlabs AI-enabled Imaging Modality Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Yorlabs (2020-2025)

Table 75. Yorlabs Recent Developments

Table 76. Nanox Basic Information List

Table 77. Nanox Description and Business Overview

Table 78. Nanox AI-enabled Imaging Modality Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI-enabled Imaging Modality Business of Nanox (2020-2025)

Table 80. Nanox Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. AI-enabled Imaging Modality Downstream Customers

Table 84. AI-enabled Imaging Modality Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. AI-enabled Imaging Modality Product Picture

Figure 2. Global AI-enabled Imaging Modality Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global AI-enabled Imaging Modality Sales Value (2020-2031) & (US$ Million)

Figure 4. AI-enabled Imaging Modality Report Years Considered

Figure 5. Global AI-enabled Imaging Modality Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI-enabled Imaging Modality Revenue in 2024

Figure 7. AI-enabled Imaging Modality Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Computed Tomography Picture

Figure 9. MRI Picture

Figure 10. X-Ray Picture

Figure 11. Ultrasound Picture

Figure 12. Positron Emission Tomography Picture

Figure 13. Others Picture

Figure 14. Global AI-enabled Imaging Modality Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global AI-enabled Imaging Modality Sales Value Market Share by Type, 2024 & 2031

Figure 16. Product Picture of Hospital

Figure 17. Product Picture of Cilinic

Figure 18. Product Picture of Labs

Figure 19. Global AI-enabled Imaging Modality Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 20. Global AI-enabled Imaging Modality Sales Value Market Share by Application, 2024 & 2031

Figure 21. North America AI-enabled Imaging Modality Sales Value (2020-2031) & (US$ Million)

Figure 22. North America AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

Figure 23. Europe AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 24. Europe AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

Figure 25. Asia Pacific AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 26. Asia Pacific AI-enabled Imaging Modality Sales Value by Region (%), 2024 VS 2031

Figure 27. South America AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 28. South America AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

Figure 29. Middle East & Africa AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 30. Middle East & Africa AI-enabled Imaging Modality Sales Value by Country (%), 2024 VS 2031

Figure 31. Key Countries/Regions AI-enabled Imaging Modality Sales Value (%), (2020-2031)

Figure 32. United States AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 33. United States AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 34. United States AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 35. Europe AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 36. Europe AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 37. Europe AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 38. China AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 39. China AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 40. China AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 41. Japan AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 42. Japan AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 43. Japan AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 44. South Korea AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 45. South Korea AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 46. South Korea AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 47. Southeast Asia AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 48. Southeast Asia AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 49. Southeast Asia AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 50. India AI-enabled Imaging Modality Sales Value, (2020-2031) & (US$ Million)

Figure 51. India AI-enabled Imaging Modality Sales Value by Type (%), 2024 VS 2031

Figure 52. India AI-enabled Imaging Modality Sales Value by Application (%), 2024 VS 2031

Figure 53. AI-enabled Imaging Modality Industrial Chain

Figure 54. AI-enabled Imaging Modality Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI-enabled Imaging Modality market? zhanKai

The top companies in the global AI-enabled Imaging Modality market are Koninklijke Philips N.V.、Siemens Healthineers AG.、General Electric Company.

Related Reports

AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 108
USD 3950.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 104
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-enabled Imaging Modality market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 123
USD 4900.00
(Single User License)
Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 78
USD 4250.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 77
USD 2900.00
(Single User License)
Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-02-06
Pages: 87
USD 2900.00
(Single User License)
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published Date: 2024-01-12
Pages: 112
USD 3950.00
(Single User License)

AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-enabled Imaging Modality was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 108
USD 3950.00 (Single User License)
Global AI-enabled Imaging Modality Market Research Report 2026
The global AI-enabled Imaging Modality market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 104
USD 2900.00 (Single User License)
Global AI-enabled Imaging Modality Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-enabled Imaging Modality market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 123
USD 4900.00 (Single User License)
Global AI-enabled Imaging Modality Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI-enabled Imaging Modality market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 78
USD 4250.00 (Single User License)
Global AI-enabled Imaging Modality Market Research Report 2025
The global market for AI-enabled Imaging Modality was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 77
USD 2900.00 (Single User License)
Global AI-enabled Imaging Modality Market Insights, Forecast to 2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-04-26
Pages: 112
USD 4900.00 (Single User License)
Global AI-enabled Imaging Modality Market Research Report 2024
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-02-06
Pages: 87
USD 2900.00 (Single User License)
AI-enabled Imaging Modality - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.
Published: 2024-01-12
Pages: 112
USD 3950.00 (Single User License)